To examine the impact of additional confounder adjustment for the potential association between second line T2DM therapy and thyroid cancer: a nested case-control study (GLP1i and thyroid cancer)

08/09/2023
13/12/2023
EU PAS number:
EUPAS106600
Study
Finalised

ENCePP Code of conduct

No
Data sources

Data source(s), other

IMRD United Kingdom

Data sources (types)

Electronic healthcare records (EHR)
Use of a Common Data Model (CDM)

CDM mapping

No
Data quality specifications

Check conformance

Unknown

Check completeness

Unknown

Check stability

Unknown

Check logical consistency

Unknown
Data characterisation

Data characterisation conducted

No
Procedures
No information provided.